miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer

Despite that androgen-deprivation therapy results in long-lasting responses, the disease inevitably progresses to metastatic castration-resistant prostate cancer. In this study, we identified miR-33b-3p as a tumor suppressor in prostate cancer. miR-33b-3p was significantly reduced in prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Yu, Li, Kai, Zhang, Zhicheng, Li, Mengmeng, Yang, Hong, Wang, Hui, Huang, Xuemei, Li, Xinyuan, Shi, Shuhua, Yang, Huanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595470/
https://www.ncbi.nlm.nih.gov/pubmed/34804930
http://dx.doi.org/10.3389/fonc.2021.740452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595470/
https://www.ncbi.nlm.nih.gov/pubmed/34804930
http://dx.doi.org/10.3389/fonc.2021.740452

Ejemplares similares